Campbell & Co Investment Adviser’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-6,523
Closed -$456K 996
2024
Q4
$456K Buy
+6,523
New +$542K 0.04% 696
2023
Q3
Sell
-3,948
Closed -$724K 909
2023
Q2
$724K Sell
3,948
-3,994
-50% -$575K 0.13% 259
2023
Q1
$1.06M Buy
+7,942
New +$933K 0.2% 138

Other funds holding ACLS

Campbell & Co Investment Adviser's ACLS Position: Q1 2025 in Review

Campbell & Co Investment Adviser sold out of Axcelis (ACLS) in Q1 2025, closing a stake of 6,523 shares — an estimated $456K sold.

Campbell & Co Investment Adviser first reported a position in ACLS in Q1 2023 and held it in 3 quarters. The position peaked at $1.06M in Q1 2023. 306 funds tracked by Wall St. Rank hold ACLS as of Q1 2025.

  • Campbell & Co Investment Adviser reported no remaining Axcelis position as of Q1 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 6,523 Axcelis shares in Q1 2025, an estimated $456K.
  • Campbell & Co Investment Adviser first reported a position in Axcelis in Q1 2023 and held it in 3 quarters.
  • Campbell & Co Investment Adviser's Axcelis position peaked at $1.06M in Q1 2023.
  • 306 funds tracked by Wall St. Rank held Axcelis as of Q1 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2025, filed 14 May 2025.